Mechanisms of apoptosis after ischemia and reperfusion: Role of the renin-angiotensin system

Apoptosis

Volumn 11, Issue 3, 2006, Pages 347-358

  Kossmehl, P ^a   Kurth, E ^a   Faramarzi, S ^a   Habighorst, B ^a   Shakibaei, M ^a,b   Wehland, M ^a   Kreutz, R ^a   Infanger, M ^a   Danser, A H J ^c   Grosse, J ^a   Paul, M ^a   Grimm, D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ACE inhibition; Apoptosis; Fas; Myocardial infarction; P53

Indexed keywords

ANGIOTENSIN I; CASPASE 3; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; QUINAPRILAT;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HEART DISEASE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SWINE;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL SHAPE; FEMALE; HEART; MYOCARDIAL INFARCTION; MYOCARDIUM; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RENIN-ANGIOTENSIN SYSTEM; REPERFUSION INJURY; SWINE; TETRAHYDROISOQUINOLINES; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 33646419771     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-4350-9     Document Type: Article

References (49)

1. Bing OHL. Hypothesis: apoptosis may be a mechanism for the transition to heart failure in rats with chronic pressure overload. J Mol Cell Cardiol 1994; 26: 943-948.
2. Rodriguez M, Lucchesi BR, Schaper J. Apoptosis in myocardial infarction. Ann Med 2002; 34: 470-479.
3. Nitahara JA, Cheng W, Liu Y, et al. Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 1998; 30: 519-535.
4. Freude B, Master TN, Kostin S, Robicsek F, Schaper J. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol 1998; 93: 85-89.
5. Chen C, Ma I, Linfert DR, et al. Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol 1997; 30: 1407-1412.
6. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628.
7. Anversa P, Cheng W, Liu Y, Len A, Redaelli G, Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol 1998; 93: 8-12.
8. Holly TA, Drincic A, Byun Y, et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 1999; 31: 1709-1715.
9. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 1996; 94: 1506-1512.
10. Cheng W, Kajstura J, Nitahara JA, et al. Reed JC, Olivetti G, Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 1996; 226: 316-327.
11. Pierzchalski P, Reiss K, Cheng W, et al. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res 1997; 234: 57-65.
12. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995; 80: 293-299.
13. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996; 74: 86-107.
14. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the bcl-2-to Bax protein ratio in the cell. J Clin Invest 1998; 101: 1326-1342.
15. Kajstura J, Cigola E, Malhotra A, et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29: 859-870.
16. Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 1997; 100: 1991-1999.
17. Long X, Boluyt MO, Hipolito ML, et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 1997; 99: 2635-2643.
18. Nogueira AC, Ast I, Patone G, Perschel FH, Grimm D, Paul M. Functional effects of acute coronary occlusion and catecholinergic stimuli on the isolated normothermic hemoperfused porcine heart. Clin Exp Hypertens 2003; 25: 235-255.
19. Kossmehl P, Schonberger J, Shakibaei M, et al. Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med 2005; 83: 626-637.
20. Farquharson CAJ, Struthers AD. Gradual reactivation over time of vascular tissue Angiotensin I to Angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. JACC 2002; 39: 767-775.
21. Mitrovic V, Mudra H, Bonzel T, Schmidt W, Schlepper M. Hemodynamic and humeral effects of parental therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure. Z Kardiol 1996; 85: 823-838.
22. Lazar HL, Bao Y, Rivers S, Colton T, Bernard SA. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg 2001; 72: 548-554.
23. Danser AH, van Kats JP, Admiraal PJ, et al. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 1994; 24: 37-48.
24. 1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension 1997; 30: 42-49.
25. Grimm D, Huber M, Jabusch HC, et al. Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure-overload: effects of beta-receptor blockade. J Mol Cell Cardiol 2001; 33: 487-501.
26. Rothermund L, Kreutz R, Kossmehl P, et al. Early onset of chondroitin sulfate and OPN expression in angiotensin II-dependent left ventricular hypertrophy. Am J Hypertens 2002; 15: 644-652.
27. Shakibaei M, Zimmermann B, Merker HJ. Changes in integrin expression during chondrogenesis in vitro: an immunomorphological study. J Histochem Cytochem 1995; 43: 1061-1069.
28. Kossmehl P, Shakibaei M, Cogoli A, et al. Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology 2003; 144: 4172-4179.
29. van Kats JP, Duncker DJ, Haitsma DB, et al. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 2000; 102: 1556-1563.
30. Maulik N, Sasaki H, Addya S, Das DK. Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett 2000; 485: 7-12.
31. Yue TL, Ma XL, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 1998; 82: 166-174.
32. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949-956.
33. Cleutjens JPM, Blankesteijn WM, Daemen MJAP, Smits JFM. Review - The infarcted myocardium - simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 1999; 44: 232-241.
34. Zhao ZQ, Nakamura M, Wang NP, et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000; 45: 651-660.
35. Biondi-Zoccai GG, Abbate A, Vasaturo F, et al. Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease. Int J Cardiol 2004; 94: 105-110.
36. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996; 28: 2005-2016.
37. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-1189.
38. Okamura T, Miura T, Takemura G, et al. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res 2000; 45: 642-650.
39. Wang LX, Ideishi M, Yahiro E, Urata H, Arakawa K, Saku K. Mechanism of the Cardioprotective Effect of Inhibition of the Renin-Angiotensin System on Ischemia/Reperfusion-Induced Myocardial Injury. Hypertens Res 2001; 24: 179-187.
40. Ruetten H, Badorff C, Ihling C, Zeiher AM, Dimmeler S. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory Effects. JACC 2001; 38: 2063-2070.
41. Odaka C, Mizuochi T. Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clin Exp Immuno. 2000; 121: 515-522.
42. Tawa P, Hell K, Giroux A, et al. Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors. Cell Death Differ 2004; 11: 439-447.
43. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vitro. Am J Physiol Heart Circ Physiol 2003; 284: 456-463.
44. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994; 75: 426-433.
45. Jeremias I, Kupatt C, Martin-Villalba A, et al. Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia. Circulation 2000; 102: 915-920.
46. Wang R, Zagariya A, Ang E, Ibarra-Sunga O, Uhal BD. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am J Physiol 1999; 277: 1245-1250.
47. Krijnen PAJ, Nijmeijer R, Meijer CJLM, Visser CA, Hack CE, Niessen HWM. Apoptosis in myocardial ischemia and infarction. J Clin Pathol 2002; 55: 801-811.
48. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994; 54: 3131-3135.
49. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-1805.